230 related articles for article (PubMed ID: 26310427)
1. GMPPB-Associated Dystroglycanopathy: Emerging Common Variants with Phenotype Correlation.
Jensen BS; Willer T; Saade DN; Cox MO; Mozaffar T; Scavina M; Stefans VA; Winder TL; Campbell KP; Moore SA; Mathews KD
Hum Mutat; 2015 Dec; 36(12):1159-63. PubMed ID: 26310427
[TBL] [Abstract][Full Text] [Related]
2. Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study.
Astrea G; Romano A; Angelini C; Antozzi CG; Barresi R; Battini R; Battisti C; Bertini E; Bruno C; Cassandrini D; Fanin M; Fattori F; Fiorillo C; Guerrini R; Maggi L; Mercuri E; Morani F; Mora M; Moro F; Pezzini I; Picillo E; Pinelli M; Politano L; Rubegni A; Sanseverino W; Savarese M; Striano P; Torella A; Trevisan CP; Trovato R; Zaraieva I; Muntoni F; Nigro V; D'Amico A; Santorelli FM;
Orphanet J Rare Dis; 2018 Sep; 13(1):170. PubMed ID: 30257713
[TBL] [Abstract][Full Text] [Related]
3. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan.
Carss KJ; Stevens E; Foley AR; Cirak S; Riemersma M; Torelli S; Hoischen A; Willer T; van Scherpenzeel M; Moore SA; Messina S; Bertini E; Bönnemann CG; Abdenur JE; Grosmann CM; Kesari A; Punetha J; Quinlivan R; Waddell LB; Young HK; Wraige E; Yau S; Brodd L; Feng L; Sewry C; MacArthur DG; North KN; Hoffman E; Stemple DL; Hurles ME; van Bokhoven H; Campbell KP; Lefeber DJ; ; Lin YY; Muntoni F
Am J Hum Genet; 2013 Jul; 93(1):29-41. PubMed ID: 23768512
[TBL] [Abstract][Full Text] [Related]
4. Late-onset limb-girdle muscular dystrophy caused by GMPPB mutations.
Balcin H; Palmio J; Penttilä S; Nennesmo I; Lindfors M; Solders G; Udd B
Neuromuscul Disord; 2017 Jul; 27(7):627-630. PubMed ID: 28478914
[TBL] [Abstract][Full Text] [Related]
5. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.
Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F
Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328
[TBL] [Abstract][Full Text] [Related]
6. Two patients with GMPPB mutation: The overlapping phenotypes of limb-girdle myasthenic syndrome and limb-girdle muscular dystrophy dystroglycanopathy.
Montagnese F; Klupp E; Karampinos DC; Biskup S; Gläser D; Kirschke JS; Schoser B
Muscle Nerve; 2017 Aug; 56(2):334-340. PubMed ID: 27874200
[TBL] [Abstract][Full Text] [Related]
7. GDP-Mannose Pyrophosphorylase B (
Chompoopong P; Milone M
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833299
[TBL] [Abstract][Full Text] [Related]
8. Mobility shift of beta-dystroglycan as a marker of
Sarkozy A; Torelli S; Mein R; Henderson M; Phadke R; Feng L; Sewry C; Ala P; Yau M; Bertoli M; Willis T; Hammans S; Manzur A; Sframeli M; Norwood F; Rakowicz W; Radunovic A; Vaidya SS; Parton M; Walker M; Marino S; Offiah C; Farrugia ME; Mamutse G; Marini-Bettolo C; Wraige E; Beeson D; Lochmüller H; Straub V; Bushby K; Barresi R; Muntoni F
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):762-768. PubMed ID: 29437916
[TBL] [Abstract][Full Text] [Related]
9. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D
Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662
[TBL] [Abstract][Full Text] [Related]
10. Expanding the phenotype of GMPPB mutations.
Cabrera-Serrano M; Ghaoui R; Ravenscroft G; Johnsen RD; Davis MR; Corbett A; Reddel S; Sue CM; Liang C; Waddell LB; Kaur S; Lek M; North KN; MacArthur DG; Lamont PJ; Clarke NF; Laing NG
Brain; 2015 Apr; 138(Pt 4):836-44. PubMed ID: 25681410
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal degradation of GMPPB is associated with limb-girdle muscular dystrophy type 2T.
Tian WT; Zhou HY; Zhan FX; Zhu ZY; Yang J; Chen SD; Luan XH; Cao L
Ann Clin Transl Neurol; 2019 Jun; 6(6):1062-1071. PubMed ID: 31211170
[TBL] [Abstract][Full Text] [Related]
12. TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α-dystroglycan and muscular dystrophy.
Larson AA; Baker PR; Milev MP; Press CA; Sokol RJ; Cox MO; Lekostaj JK; Stence AA; Bossler AD; Mueller JM; Prematilake K; Tadjo TF; Williams CA; Sacher M; Moore SA
Skelet Muscle; 2018 May; 8(1):17. PubMed ID: 29855340
[TBL] [Abstract][Full Text] [Related]
13. Congenital muscular dystrophy and generalized epilepsy caused by GMPPB mutations.
Raphael AR; Couthouis J; Sakamuri S; Siskind C; Vogel H; Day JW; Gitler AD
Brain Res; 2014 Aug; 1575():66-71. PubMed ID: 24780531
[TBL] [Abstract][Full Text] [Related]
14. Novel mutations in the C-terminal region of GMPPB causing limb-girdle muscular dystrophy overlapping with congenital myasthenic syndrome.
Luo S; Cai S; Maxwell S; Yue D; Zhu W; Qiao K; Zhu Z; Zhou L; Xi J; Lu J; Beeson D; Zhao C
Neuromuscul Disord; 2017 Jun; 27(6):557-564. PubMed ID: 28433477
[TBL] [Abstract][Full Text] [Related]
15. A founder mutation in the GMPPB gene [c.1000G > A (p.Asp334Asn)] causes a mild form of limb-girdle muscular dystrophy/congenital myasthenic syndrome (LGMD/CMS) in South Indian patients.
Polavarapu K; Mathur A; Joshi A; Nashi S; Preethish-Kumar V; Bardhan M; Sharma P; Parveen S; Seth M; Vengalil S; Chawla T; Shingavi L; Shamim U; Nayak S; Vivekanand A; Töpf A; Roos A; Horvath R; Lochmüller H; Nandeesh B; Arunachal G; Nalini A; Faruq M
Neurogenetics; 2021 Oct; 22(4):271-285. PubMed ID: 34333724
[TBL] [Abstract][Full Text] [Related]
16. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea.
Lim BC; Ki CS; Kim JW; Cho A; Kim MJ; Hwang H; Kim KJ; Hwang YS; Park WY; Lim YJ; Kim IO; Lee JS; Chae JH
Neuromuscul Disord; 2010 Aug; 20(8):524-30. PubMed ID: 20620061
[TBL] [Abstract][Full Text] [Related]
17. Telethonin-deficiency initially presenting as a congenital muscular dystrophy.
Ferreiro A; Mezmezian M; Olivé M; Herlicoviez D; Fardeau M; Richard P; Romero NB
Neuromuscul Disord; 2011 Jun; 21(6):433-8. PubMed ID: 21530252
[TBL] [Abstract][Full Text] [Related]
18. A novel homozygous ISPD gene mutation causing phenotype variability in a consanguineous family.
Baranello G; Saredi S; Sansanelli S; Savadori P; Canioni E; Chiapparini L; Balestri P; Malandrini A; Arnoldi MT; Pantaleoni C; Morandi L; Mora M
Neuromuscul Disord; 2015 Jan; 25(1):55-9. PubMed ID: 25444434
[TBL] [Abstract][Full Text] [Related]
19. Clinical and electrophysiological evaluation of myasthenic features in an alpha-dystroglycanopathy cohort (FKRP-predominant).
Gonzalez-Perez P; Smith C; Sebetka WL; Gedlinske A; Perlman S; Mathews KD
Neuromuscul Disord; 2020 Mar; 30(3):213-218. PubMed ID: 32115343
[TBL] [Abstract][Full Text] [Related]
20. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
